Could common pills boost cancer treatment? new melanoma trial investigates
Disease control
Recruiting now
This early-stage study is checking if it's safe to add two common, low-cost drugs—naltrexone and propranolol—to standard immunotherapy for advanced melanoma. The idea is that these drugs, which block the body's stress response, might help the immune system fight cancer better. Re…
Phase: PHASE1 • Sponsor: Sarah Weiss • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC